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Objective This study was performed to determine the ability of the VITAL system to
detect and allow recovery of microorganisms that are difﬁcult to grow, such as Brucella
spp., yeasts, or anaerobes, as well as to determine the need for blind subcultures after the
incubation period.
Methods A prospective evaluation of the systemwas performed, and 8247 blood culture
bottles were processed. The standard was blind subculture from all the bottles after
5 days of incubation.
Results There were 3.2% false-positive and 0.6% false-negative results (72% of clinical
importance). The system sensitivity for yeasts was 41%. The mean time for detection of
Neisseria meningitidis was 31.9 2.8 h, for Brucella spp. 119.7 2 h, and for yeast
51.5 27.8 h.
Conclusions The VITAL system poses has serious difﬁculties in the detection of
N.meningitidis, Brucella spp., yeast and methicillin- and aminoglycoside-resistant Sta-
phylococcus aureus (MARSA). The low system sensitivity for yeast detection makes the
blind subculture necessary after the incubation period.
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INTRODUCTION
The presence of living microorganisms in the
blood is of critical importance in infectious pathol-
ogy. This fact confers great importance on the
technological efforts to achieve an early diagnosis
and appropriate treatment.
In the last few years, many automated blood
culture systems have been commercialized, offer-
ing several apparent advantages in performance,
specimen capacity, cost and safety over the tradi-
tional methods [1–3]. The choice of culture system
must be based on the results obtained in objective
clinical evaluations. Manufacturers of automated
blood culture systems state that terminal culture is
not necessary, although in system evaluations it
must be carried out so that the false-negative rate
can be determined [4]. The system is failing in its
main purpose if false negatives occur and there
can be important clinical implications if organisms
are not detected. The VITAL system differs from
others as it uses a unique method to detect micro-
bial growth. A ﬂuorescent molecule is altered in its
conformation by pH changes, redox potential var-
iations and CO2 production. Decrease in ﬂuores-
cence related to time is measured by non-invasive
procedures. Although the VITAL system is being
used in Europe, not enough data have been pub-
lished about sensitivity, speciﬁcity and detection
speed, especially for microorganisms that are dif-
ﬁcult to grow such as yeast, Brucella spp. and
anaerobes.
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MATERIALS AND METHODS
A prospective evaluation of the VITAL system
(bioMe´rieux, Marcy-L’Etoile, France) was per-
formed by analyzing 8247 blood culture bottles
during a period of 10months. In adult patients, a
volume of 10mL of blood each time was obtained
in two extractions separated by 30min, and inocu-
lated at random into two culture medium bottles,
aerobic and anaerobic, respectively. In children,
only an aerobic bottle was inoculated. The volume
of blood depended on the age of the child and was
a minimum of 1mL in newborns. An anaerobic
bottle was inoculated only when clinical suspicion
of anaerobic infection was high. The incubation
period lasted 5 days, after it had been determined
that incubation of 5 or 7 days did not change the
number of clinically important isolations. When
brucellosis, endocarditis, or fungemia were sus-
pected, blood cultures were reincubated for up to
30 days (10 days in the VITAL system when bru-
cellosis was suspected).
The reference standardwas the blind subculture
of all the bottles after 5 days of incubation. The
media used for subculture were chocolate agar
and Schaedler agar (bioMe´rieux SA) with a 2-
day incubation in an aerobic atmosphere with 5–
10% CO2 and in an anaerobic atmosphere, respec-
tively. A prospective evaluation and follow-up of
all the patients showing positive blood cultures
were performed by patient evaluation, chart
review and also by consensus between the micro-
biological staff and the clinicians, with the aim of
establishing the site of infection, providing gui-
dance on treatment, and ruling out contamination.
A result was considered to be false positive if the
system detected a positive but both Gram stain
and culture were negative, and to be false negative
if the system detected a negative but one or more
microorganisms were isolated on blind subcul-
ture.
The results obtained were evaluated according
to common standards [5], considering as adequate
a positive blood cultures rate8%, a false-negative
rate 0.5%, a false-positive rate 2% and a con-
tamination rate 3%.
RESULTS
A total of 8247 blood culture bottles were pro-
cessed during the evaluation period: 1359 of them
(16.4%) were detected as positive by the system,
and 1138 (13.7%) by the referencemethod; 8.12% of
themwere considered to be of clinical signiﬁcance.
The contamination rate was 5.6% and the false-
positive rate was 3.2%. The system did not detect
microbial growth in 51 samples (0.6% of blood
cultures extracted), and 37 of these (72%) showed
clinical signiﬁcance. Sensitivity, speciﬁcity, posi-
tive predictive value and negative predictive value
are shown in Table 1. The VITAL system sensitiv-
ity for yeast detection was 41%.
Detection times of growth for Gram-negative
and -positive organisms are shown in Tables 2
and 3.
Table 1 VITAL system sensitivity and specificity
Total blood culture bottles 8247





Total positives VITAL 1359 (16.4%)
Total positives with clinical
significance
619 (7.5%)
Total contaminated 468 (5.6%)
Total false positives 272 (3.2%)




Sensitivity for yeast 41% (n¼ 51)
Specificity 96.1%
Positive predictive value 79.9%
Negative predictive value 99.2%






Escherichia coli 110 15.2 2.35
Proteus mirabilis 12 16.15 3.46
Klebsiella pneumoniae 7 10.85 2.43
Klebsiella oxytoca 10 32.35 13.51
Enterobacter spp. 18 22.7 11
Serratia spp. 12 10.15 1.7
Salmonella spp. 13 34.2 10.3
Morganella morganii 1 113 –
Pseudomonas aeruginosa 55 35.7 2.83
Pseudomonas stutzeri 5 42.5 7.79
Haemophilus influenzae 10 17.8 8.10
Haemophilus parainfluenzae 2 60.6 –
Brucella spp.a 5 119.7 21.1
Campylobacter jejuni 2 60.8 –
Capnocytophaga sp. 1 34.15 –
Neisseria meningitidis 5 31.9 2.8
Bacteroides fragilis 2 70.7 –
aIncubation period¼ 10days.
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During the evaluation period, 10 strains of Cryp-
tococcus neoformans were isolated. The VITAL sys-
tem detected only one of them, in 22 h. As for the
mean time to detect other yeast, no differences
were observed between species. The 21 yeast
strains were detected in 51.5 27.8 h (Table 4).
During this period, 272 bottles (3.2%) were
detected as positive without any microorganism
in the subculture (system false positive). The mean
time for detection was 88.7 h with a standard
deviation of 3.8 h. Before the introduction of the
VITAL system, blood cultures were analyzed
visually (conventional method) to detect macro-
scopic signs of growth. During this period the
number of false positives was 3.4%, only slightly
higher than with the automatic system.
Four hundred and sixty-eight isolates (5.6%),
mainly coagulase-negative staphylococci, were
considered as contaminants. They were detected
after approximately 48 h of incubation (46.7
6.6 h), i.e. 10 h more than the time needed to isolate
the same microorganism when it had clinical
signiﬁcance.
In 51 (0.6%) cases, no growth was detected by
the system while a microorganism was isolated in
the blind subculture. Table 5 shows microorgan-
isms that were not detected by the system. Among
the false negatives, four were aerobic Gram-posi-
tive cocci, two of them methicillin- and aminogly-
coside-resistant Staphylococcus aureus (MARSA)
strains, nine were aerobic and facultatively anae-
robic Gram-negative bacteria, and ﬁve were anae-
robic Gram-negative rods (two of which were not
detected on the speciﬁc bottle).
Among the 30 yeast detected by the system, 13
were isolated on blind subculture from the aerobic
bottle, the one with the best conditions for its
growth. These isolates were from 25 patients, 12
of whom would not have been diagnosed without
the reference method (Table 6).
Table 3 Time to detection of Gram-positive cocci and






Staphylococcus aureus 62 20.7 2.2
Staphylococcus aureus (MRSA) 11 38 8.5




Streptococcus pneumoniae 52 10.4 5.35
Enterococcus faecalis 17 9.81 2
Enterococcus faecium 2 2.3 –
Enterococcus durans 2 8.7 –
Streptococcus pyogenes 2 17 –
Streptococcus agalactiae 6 5.6 1.3
b-Haemolytic streptococci
(groups C and G)
3 12.45 –
Viridans group streptococci 24 18.3 2.7
Peptostreptococcus sp. 1 103.3 –
Listeria monocytogenes 6 18.9 4.4
Erysipelothrix rhusiopathiae 2 58.7 –
Clostridium spp. 2 28.3 –






Candida albicans 8 54.7 17.7
Candida tropicalis 7 45.7 33.8
Candida parapsilosis 3 80.4 –
Candida glabrata 1 8.15 –
Candida krusei 1 52.15 –
Cryptococcus neoformans 1 22 –
Total 21 51.5 27.8









Staphylococcus epidermidis – 1 1
Streptococcus milleri 1 – 1
Erysipelothrix rhusiopathiae 1 – 1
Escherichia coli 3 1 4
Klebsiella pneumoniae 1 – 1
Salmonella typhi 1 – 1
Moraxella catarrhalis 1 – 1
Brucella spp. – 2 2
Bacteroides fragilis 2 2 4
Fusobacterium sp. 1 – 1
Total 12 7 19






Candida albicans 4 7 11
Candida parapsilosis 3 1 4
Candida glabrata – 1 1
Candida krusei 1 1 2
Candida spp. 1 2 3
Cryptococcus neoformans 4 5 9
Total 13 17 30
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DISCUSSION
The replacement of conventional blood culture
methods, implying early and late blind subcul-
tures, by automated blood culture systems has
improved the process of positive blood culture
detection in sensitivity, speciﬁcity and speed,
thanks to the agitation mechanism and continuous
reading. These systems have also reduced the
workload signiﬁcantly. Thus, they are highly
recommended for laboratories receiving more
than 10 blood cultures per day. The automated
systems have also, by eliminating blind subcul-
tures, reduced the risk of accidental punctures by
which infectious diseases, such as acquired
immune deﬁciency syndrome (AIDS) or hepatitis,
can be transmitted. This is particularly important
in hospitals with a high number of these patients
[30% of blood cultures sent to the Microbiology
Department of our hospital during the study per-
iod came from human immunodeﬁciency virus
(HIV)-positive patients, so that the risk of infection
after an accidental puncturewas about 1.5 per 1000
blood cultures.
The use of an automated method also has some
disadvantages, the most important being the addi-
tional economic cost or the limited medium types
with some systems. For these reasons, it is essential
to obtain the results from evaluations of these new
systems in clinical laboratories, and to compare
them with others, before their introduction.
The VITAL automated blood culture system
was commercialized in 1993, and was distributed
throughout Europe. VITAL differs from other sys-
tems mainly in its use of a unique and speciﬁc
method for growth detection, based on the pre-
sence of a ﬂuorescent compound. To date, only a
few studies of the system have been published
[6,7]. Thus, we considered its thorough evaluation
essential before introducing the system into our
laboratory.
The speed of detection of different microorgan-
isms by the VITAL system was assessed. In the
case of Enterobacteriaceae, the mean time of
detection (20.2 9.1) was similar to that of other
continous-monitoring blood culture systems,
such as BacT/Alert [8] or Bactec 9240 [9]. This
means a signiﬁcantly earlier detection of microbial
growth of these microorganisms compared to
the semiautomatic systems (Bactec NR 660) [10]
and to the visual monitoring of conventional
methods [11].
The mean time for detection of 10 Haemophilus
inﬂuenzae strains isolated was similar to that of
Enterobacteriaceae (17.8 8.10), agreeing with the
data brought forward by other authors [1,8]. How-
ever, there was an important system delay in
Neisseria meningitidis detection (31.9 2.8 h); in
Bactec 460, Bactec 9240 and BacT/Alert systems,
the times of detection being 19.9, 19 and 14 h,
respectively [1,9]. This is relevant because of the
importance of rapid diagnosis of N.meningitidis
bacteraemia both in a paediatric population, in
which it is an important cause of occult bacterae-
mia, sepsis and/or meningitis [12,13], and in
adults.
The VITAL system detected ﬁve strains of
Brucella spp. in a mean time of 5 days, and two
strains were isolated only on blind subculture.
This is an improvement over semiautomatic sys-
tems such as Bactec NR660, which only detect 42%
of strains after approximately the seventh day of
incubation [14]. Yet, in a recent study [15], com-
paring Bactec 9240 with biphasic media Hemoline
(bioMe´rieux) and VITAL, 94.1% of the strains
were detected before 7 days, while the other two
systems only detected 76.5 and 47.1% of the
strains, respectively, in this time. Anaerobic
Gram-negative rods were detected in a mean time
of 70.7 31.2 h, which does not differ from the
time needed by other continuous-monitoring
blood culture systems.
The mean time for detection of S. aureus was
20.7 2.2 h, faster than semiautomatic systems,
which detect 50% of the strains in 3 days [10],
and conventional systems, which take 53 18 h
as a mean time until microbial growth visualiza-
tion. We could not ﬁnd any reference to the detec-
tion time of MARSA in the published works about
automated systems. In our study, it is higher
(38 8.5) than for methicillin-susceptible strains
(20.7 2.2 h). This fact could be due to differential
features of MARSA, such as the ability to produce
signiﬁcantly higher amounts of coagulase [16,17]
favoring the formation of aggregates which might
be more difﬁcult to detect, or to the fact that the
chromosomal mec gene increases its tendency
towards cellular autolysis [18].
Among Gram-positive cocci with clinical signif-
icance, coagulase-negative staphylococci and
MARSA take longer to detect (30.85 3.1 h). Slime
production by coagulase-negative staphylococci
could favor aggregate formation and make them
difﬁcult for the system to detect.
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As regards streptococci, the earliest detection
time was for Streptococcus agalactiae (5.6 1.3 h),
followed by S. pneumoniae (10.4 5.35 h) and by b-
haemolytic streptococcus group C and G
(14.7 1.7). The rapidity of the system in detecting
this group is an important advantage, mainly in
the case of S. pneumoniae, which has a strong ten-
dency to autolysis.
Detection by the VITAL system of Erysipelothrix
rhusiopathiae bacteraemia (58.7 0.57 h) was essen-
tial for the diagnosis and early therapy of a patient
with endocarditis [19].
In the VITAL automatic system, the mean time
of detection for yeast was slightly longer (about
3 days) and the detection rate lower (50%) than for
Bactec NR 460 or for lysis-centrifugation [20].
One of the main disadvantages of the visual
reading method is the number of bottles consid-
ered to be visually positive but which have nega-
tive subcultures (3.4% during the period studied).
This creates an extra workload for laboratory
technical staff. Although automated systems have
not eliminated this problem completely, they have
decreased the false-positive rate, which should
always be equal to or lower than 2% [5]. During
our evaluation of the VITAL system, this rate was
3.2%, higher than for the semiautomatic Bactec NR
660, which was introduced to the market in 1972
[21]. A high rate of false-positive blood cultures
could mean that there is a problem in the system
algorithms for positivity detection. An example
could be the instrument’s difﬁculty in distinguish-
ing between CO2 production by blood cells or by
microbial growth [2]. The mean time for detection
of those bottles considered false positivewas 88.7 h
(over 3 days), meaning that the damage of the
culture media during incubation (more evident
on anaerobic bottles) leads to a loss of the ﬂuor-
escence that indicates positivity. Another possible
explanation of the high number of false-positive
results in the anaerobic bottle could be the ten-
dency to inoculate an excess of blood (more than
10mL), favored by the negative pressure in the
bottle. The leukocytes in this high blood volume
would produce enough CO2 to cause the system to
indicate the bottle as positive [5].
During the evaluation period, 5.6% of blood
cultures were considered as contaminated, most
of them being coagulase-negative staphylococci.
Their mean time of detection was 46.7 6.6 h,
much higher than for those with clinical signiﬁ-
cance (27.4 2.19). This may be the result of low
inoculum in the cases of contamination. These
data, together with a Gram stain, can contribute
to the distinction of contamination from a true
positive, lowering the social and economic costs
of unnecessary antibiotic therapy or admission to
the hospital [22].
The false-negative rate of the evaluated system
was 0.6%, slightly higher than considered accep-
table (0.5%) [5] and with a large number of clini-
cally signiﬁcant isolations (73%), compared to 25%
[5], which is the maximum tolerable. Among
Gram-positive cocci, MARSA was recovered twice
from blind subculture, implying system limita-
tions for growth detection of this microorganism.
Two strains of Brucella spp. were isolated on
blind subculture (29% of the total), meaning that
the 5 days chosen as the incubation period for the
VITAL system is obviously not enough for this
microorganism. Brucellosis is endemic in Spain,
yet blood cultures are often made without any
clinical suspicion, because this disease produces
non-speciﬁc symptoms, similar to those in other
infectious or non-infectious illnesses. Hence, it is of
great importance that automated blood culture
systems are able to detect Brucella spp. growth
before 5–7 days of incubation. Otherwise, the
importance of blood cultures would be underes-
timated, and the diagnosis and appropriate treat-
ment of the disease would be delayed [14].
Fungemia is a severe infection in patients suf-
fering from inmunosuppression and in patients
following major surgery. Most of the time, clinical
manifestations do not suggest a fungal aetiology;
as a result, diagnosis is based on microbiological
ﬁndings. Recently, the number of fungemia cases
has been increasing—especially candidaemia,
because of the larger number of patients at risk
(haematological neoplasia, bone marrow trans-
plantation, AIDS) [23,24]. Therefore, it is essential
to determine fast and sensitive microbiological
techniques to isolate yeast and ﬁlamentous fungi
from blood.
The largest number of false-negative results in
the VITAL system was for yeast. About 50% of the
patients would not have been diagnosed without
blind subculture at the endof the incubationperiod.
The high rate of inmunosuppressed patients in our
hospital (mainly solid and haematological neo-
plasia and AIDS) explains the high incidence of
fungemia, 70% of them due to yeast of the Candida
genus. Several evaluations [20,25,26] show that
the most effective method for the recovery of
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ﬁlamentous fungi and C. neoformans is lysis-cen-
trifugation. Nowadays, automated systems have a
yeast detection rate similar to the lysis-centrifuga-
tion rate [8]. Thus, lysis-centrifugation is only
applied in those areas where such fungi as Histo-
plasma capsulatum or Coccidioides immitis are ende-
mic or where there is a large number of HIV-
infected patients. In our study, 30% of false nega-
tives for yeast were C. neoformans strains. This is a
yeast with a low metabolic activity, so that the
available automated systems often cannot detect it
in a ﬁve-day period, despite there being a large
number of colonies in the blind subculture.
Among the advantages of the automated sys-
tems, manufacturers point out that late subculture
is not required [27,28]. Nevertheless, on any eva-
luation a reference standard is essential in order to
establish accurately the number of false negatives
and their clinical importance [29]. In our case, as
the sensitivity of the system speciﬁcally for yeast
was 41%, blind subculture at the end of the incu-
bation period cannot be avoided.
Convenience will depend not only on the sys-
tem used but also on the type of patient admitted
to the hospital, on the sensitivity of the system and
on the false-negative rate obtained in preliminary
evaluations, before the system can be used in the
diagnostic laboratory.
In conclusion, VITAL (bioMe´rieux) is an ade-
quate system for the detection of the main micro-
organisms causing bacteraemia. However, despite
the richness of the broth media allowing growth of
every microorganism isolated in blind subculture,
the software system has great difﬁculties in detect-
ing N.meningitidis, Brucella spp., yeast and
MARSA. The low sensitivity for the detection of
the genus Candida entails a blind subculture after
the incubation period, for patients of the type that
we see in our hospital. Our ﬁndings have led us to
evaluate this system negatively and to withdraw it
from daily use in our laboratory.
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